Several ASX shares rose well over 4% yesterday. This includes Cimic Group Ltd (ASX: CIM), up 8%, and Dicker Data Ltd (ASX: DDR), up 6.85%. However, it was the movement of two acknowledged growth shares that caught my attention.
Pro Medicus Limited (ASX: PME)
This ASX share price leapt by 6.66% after signing a $10 million deal with a Munich-based university. Ludwig-Maximilians-Universität (LMU Klinikum) is one of the largest university hospitals in Germany. Consequently, the deal will see the Pro Medicus technology, Visage, deployed throughout LMU Klinikum’s radiology and subspecialty imaging departments. Thus replacing systems from legacy vendors.
“We look forward to taking our partnership with Visage to the next level as we implement their technology across our radiology department,” said Dr Kurt Kruber, CIO of LMU Klinikum. “The Visage platform provides a highly scalable and reliable platform combined with sophisticated clinical features that will support us in both day-to-day patient care and advanced research.”
Dr Kurt added that large European teaching hospitals had standardised on IT platforms from large, multinational imaging equipment vendors. This underlines the importance of the deal as a breakthrough for this pioneering ASX share. The Pro Medicus share price has risen by 14.3% in 5 days of trading after announcing another international deal on 15 October.
WiseTech Global Ltd (ASX: WTC)
WiseTech saw its ASX share price rise by 4.43% yesterday. This was after news that company CEO, Richard White, would be selling the corporate headquarters acquired four years ago. This is part of an ongoing commitment by the billionaire CEO to stop doing private business with a public company by the end of 2021.
The property is a sale-and-leaseback deal, with WiseTech as the major tenant on a five-year lease. Moreover, the building was customised to match the requirements of this ASX share.
However, this clarification of interests is not the only tailwind behind WiseTech these days. The company’s recent annual report disclosed a 23% increase in revenues compared to FY19 performance. In addition, earnings before interest, taxes, depreciation and amortisation (EDITDA) rose by 17% against FY19.
Despite the impacts of COVID-19, the company sustained very low attrition rates, and reducing the company reliance on its top 10 customers, down 2% from FY19to 20% of revenue. This isolates WiseTech from impacts of losing large clients.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Dicker Data Limited and Pro Medicus Ltd. The Motley Fool Australia owns shares of WiseTech Global. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- Afterpay (ASX:APT) share price under heavy fire from industry giants – November 30, 2020 9:22am
- IOOF (ASX:IFL) accused of butchering its share price – November 25, 2020 1:58pm
- The Objective Corp (ASX:OCL) share price is up ahead of AGM – November 25, 2020 10:58am